City Therapeutics, Inc. Common Stock Cash Flow Quality Index
City Therapeutics, Inc. Common Stock cash flow quality index. City Therapeutics, Inc. Common Stock (CTY) has a Cash Flow Quality Index of 1.63x as of June 2020. Operating cash flow of $699.00 Million exceeds net income of $430.00 Million, indicating high earnings quality where cash backs reported profits. See CTY FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of City Therapeutics, Inc. Common Stock (2005–2019)
Cash flow quality index of City Therapeutics, Inc. Common Stock from 2005 to 2019. Historical Cash Flow Quality Index for City Therapeutics, Inc. Common Stock across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CTY operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
City Therapeutics, Inc. Common Stock Cash Flow Quality Index by Year (2005–2019)
City Therapeutics, Inc. Common Stock cash flow quality index by year from 2005 to 2019. Year-by-year earnings quality comparison for City Therapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see City Therapeutics, Inc. Common Stock cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 1.82x | $3.33 Billion | $1.83 Billion | ▼ -19.9% |
| 2018 | 2.28x | $3.79 Billion | $1.67 Billion | ▲ +54.9% |
| 2017 | 1.47x | $2.44 Billion | $1.66 Billion | ▼ -39.9% |
| 2016 | 2.44x | $2.65 Billion | $1.08 Billion | ▲ +1.3% |
| 2015 | 2.41x | $2.59 Billion | $1.07 Billion | ▼ -16.5% |
| 2014 | 2.89x | $2.80 Billion | $970.00 Million | ▲ +2.6% |
| 2013 | 2.81x | $2.71 Billion | $964.00 Million | ▼ -13.9% |
| 2012 | 3.27x | $2.77 Billion | $849.00 Million | ▼ -19.4% |
| 2011 | 4.05x | $2.20 Billion | $543.00 Million | ▲ +35.6% |
| 2010 | 2.99x | $3.23 Billion | $1.08 Billion | ▲ +13.0% |
| 2009 | 2.65x | $3.17 Billion | $1.20 Billion | ▲ +9.4% |
| 2008 | 2.42x | $3.48 Billion | $1.44 Billion | ▲ +10.7% |
| 2007 | 2.18x | $3.26 Billion | $1.49 Billion | ▼ -16.1% |
| 2006 | 2.60x | $3.13 Billion | $1.20 Billion | ▼ -25.5% |
| 2005 | 3.50x | $3.42 Billion | $977.00 Million | — |